Theravance Biopharma Announces Presentations at Upcoming Investor Conferences
SVB Leerink 9th Annual Global Healthcare Conference at11:30 a.m. ET (8:30 a.m. PT /4:30 p.m. GMT ) onWednesday, February 26, 2020
Cowen and Company 40th AnnualHealth Care Conference at1:30 p.m. ET (10:30 a.m. PT /6:30 p.m. GMT ) onMonday, March 2, 2020
Webcasts of the presentations may be accessed by visiting the Investor Relations section of
About
In pursuit of our purpose, we apply insights and innovation at each stage of our business and utilize our internal capabilities and those of partners around the world. We apply organ-selective expertise to biologically compelling targets to discover and develop medicines designed to treat underserved localized diseases and to limit systemic exposure, in order to maximize patient benefit and minimize risk. These efforts leverage years of experience in developing lung-selective medicines to treat respiratory disease, including
We have an economic interest in potential future payments from
For more information, please visit www.theravance.com.
THERAVANCE® and the Cross/Star logo are registered trademarks of the
Contact Information:
Corporate Communications and Investor Relations
917-214-6603
investor.relations@theravance.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/theravance-biopharma-announces-presentations-at-upcoming-investor-conferences-301005722.html
SOURCE